Company news

Xenon Pharmaceuticals Inc. news in 2024

Xenon Pharmaceuticals Inc.'s news releases, calls and decks from 2024, newest first.

View company

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

December 5, 2024

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

November 24, 2024

Xenon Reports Q3 2024 Financial Results and Business Update

November 11, 2024

Xenon to Report Q3 2024 Financial Results on November 12, 2024

November 4, 2024

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

October 1, 2024

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

September 8, 2024

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer

August 11, 2024

Xenon to Report Q2 2024 Financial Results on August 8, 2024

July 31, 2024

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

June 4, 2024

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

May 27, 2024

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 8, 2024

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

May 7, 2024

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

May 6, 2024

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

May 1, 2024

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

April 15, 2024

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

April 9, 2024

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

April 3, 2024

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days

March 11, 2024

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024

March 4, 2024

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

February 28, 2024

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

February 21, 2024

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024

January 7, 2024

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

Calls in 2024